Novel pathway for iron deficiency in pediatric non-alcoholic steatohepatitis

Clinical Nutrition

Volumn 34, Issue 3, 2015, Pages 549-556

  Moya, Diana ^a,b   Baker, Susan S ^a,b   Liu, Wensheng ^a,b   Garrick, Michael ^a   Kozielski, Rafal ^b   Baker, Robert D ^a,b   Zhu, Lixin ^a,b  

^a UNIVERSITY AT BUFFALO   (United States)

^b CHILDREN S HOSPITAL OF BUFFALO   (United States)

Author keywords

Catalase; Hydrogen peroxide; NHANES; Transferrin; Transferrin receptor 2

Indexed keywords

CATALASE; CD71 ANTIGEN; FERRITIN; HYDROGEN PEROXIDE; IRON; MESSENGER RNA; TRANSFERRIN; TRANSFERRIN RECEPTOR 2; TFR2 PROTEIN, HUMAN; TRANSFERRIN RECEPTOR;

ADOLESCENT; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; HEPG2 CELL LINE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN INDUCTION; REAL TIME POLYMERASE CHAIN REACTION; UNITED STATES; ANEMIA, IRON-DEFICIENCY; BLOOD; BODY MASS; CASE CONTROL STUDY; CHILD; COMPLICATION; DRUG EFFECTS; GENETICS; LIVER; METABOLISM; NUTRITION; NUTRITIONAL STATUS; OXIDATIVE STRESS; PATHOLOGY; YOUNG ADULT;

ADOLESCENT; ANEMIA, IRON-DEFICIENCY; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILD; FEMALE; FERRITINS; HEP G2 CELLS; HUMANS; HYDROGEN PEROXIDE; IRON; LIVER; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION SURVEYS; NUTRITIONAL STATUS; OXIDATIVE STRESS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, TRANSFERRIN; RNA, MESSENGER; TRANSFERRIN; YOUNG ADULT;

EID: 84928651171     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2014.06.011     Document Type: Article

References (29)

1. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
2. Bonkovsky H.L., Jawaid Q., Tortorelli K., LeClair P., Cobb J., Lambrecht R.W., et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. Journal of Hepatology 1999, 31:421-429.
3. George D.K., Goldwurm S., MacDonald G.A., Cowley L.L., Walker N.I., Ward P.J., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 1998, 114:311-318.
4. Fargion S., Mattioli M., Fracanzani A.L., Sampietro M., Tavazzi D., Fociani P., et al. Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. Am J Gastroenterol 2001, 96:2448-2455.
5. Valenti L., Dongiovanni P., Fracanzani A.L., Santorelli G., Fatta E., Bertelli C., et al. Increased susceptibility to nonalcoholic fatty liver disease in heterozygotes for the mutation responsible for hereditary hemochromatosis. Dig Liver Dis 2003, 35:172-178.
6. Nelson J.E., Bhattacharya R., Lindor K.D., Chalasani N., Raaka S., Heathcote E.J., et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 2007, 46:723-729.
7. Bugianesi E., Manzini P., D'Antico S., Vanni E., Longo F., Leone N., et al. Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver. Hepatology 2004, 39:179-187.
8. Chitturi S., Weltman M., Farrell G.C., McDonald D., Kench J., Liddle C., et al. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity. Hepatology 2002, 36:142-149.
9. Younossi Z.M., Gramlich T., Bacon B.R., Matteoni C.A., Boparai N., O'Neill R., et al. Hepatic iron and nonalcoholic fatty liver disease. Hepatology 1999, 30:847-850.
10. Aigner E., Theurl I., Theurl M., Lederer D., Haufe H., Dietze O., et al. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. The American Journal of Clinical Nutrition 2008, 87:1374-1383.
11. Zimmermann A., Zimmermann T., Schattenberg J., Pottgen S., Lotz J., Rossmann H., et al. Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome. Eur J Intern Med 2011, 22:305-310.
12. Manco M., Alisi A., Real J.M., Equitani F., Devito R., Valenti L., et al. Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease. Journal of Hepatology 2011, 55:647-653.
13. Liu W., Baker S.S., Baker R.D., Nowak N.J., Zhu L. Upregulation of hemoglobin expression by oxidative stress in hepatocytes and its implication in nonalcoholic steatohepatitis. PloS One 2011, 6:e24363.
14. Zhu L., Baker S.S., Liu W., Tao M.H., Patel R., Nowak N.J., et al. Lipid in the livers of adolescents with nonalcoholic steatohepatitis: combined effects of pathways on steatosis. Metabolism: Clinical and Experimental 2011, 60:1001-1011.
15. Baker S.S., Baker R.D., Liu W., Nowak N.J., Zhu L. Role of alcohol metabolism in non-alcoholic steatohepatitis. PloS One 2010, 5:e9570.
16. Yanoff L.B., Menzie C.M., Denkinger B., Sebring N.G., McHugh T., Remaley A.T., et al. Inflammation and iron deficiency in the hypoferremia of obesity. International Journal of Obesity 2007, 31:1412-1419.
17. Nead K.G., Halterman J.S., Kaczorowski J.M., Auinger P., Weitzman M. Overweight children and adolescents: a risk group for iron deficiency. Pediatrics 2004, 114:104-108.
18. McClung J.P., Karl J.P. Iron deficiency and obesity: the contribution of inflammation and diminished iron absorption. Nutr Rev 2009, 67:100-104.
19. Beguin Y. Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clin Chim Acta 2003, 329:9-22.
20. Werts E.D., Gibson D.P., Degowin R.L. Chronic inflammation suppresses bone marrow stromal cells and medullary erythropoiesis. JLab Clin Med 1979, 93:995-1003.
21. Valenti L., Fracanzani A.L., Dongiovanni P., Bugianesi E., Marchesini G., Manzini P., et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 2007, 102:1251-1258.
22. Beaton M.D., Chakrabarti S., Levstik M., Speechley M., Marotta P., Adams P. Phase II clinical trial of phlebotomy for non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2013, 37:720-729.
23. Chen C., Wen S., Tan X. Molecular analysis of a novel case of congenital atransferrinemia. Acta Haematol 2009, 122:27-28.
24. Raja K.B., Pountney D.J., Simpson R.J., Peters T.J. Importance of anemia and transferrin levels in the regulation of intestinal iron absorption in hypotransferrinemic mice. Blood 1999, 94:3185-3192.
25. Bartnikas T.B., Andrews N.C., Fleming M.D. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 2011, 117:630-637.
26. Younossi Z.M., Gorreta F., Ong J.P., Schlauch K., Del Giacco L., Elariny H., et al. Hepatic gene expression in patients with obesity-related non-alcoholic steatohepatitis. Liver Int 2005, 25:760-771.
27. Wallace D.F., Summerville L., Lusby P.E., Subramaniam V.N. First phenotypic description of transferrin receptor 2 knockout mouse, and the role of hepcidin. Gut 2005, 54:980-986.
28. Gao J., Chen J., Kramer M., Tsukamoto H., Zhang A.S., Enns C.A. Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab 2009, 9:217-227.
29. Idzerda R.L., Huebers H., Finch C.A., McKnight G.S. Rat transferrin gene expression: tissue-specific regulation by iron deficiency. Proc Natl Acad Sci U S A 1986, 83:3723-3727.